Pharmacotherapeutic management of autism

Expert Opinion on Pharmacotherapy
David J Posey, C J McDougle

Abstract

There are no medications that are specifically marketed for the treatment of autism. There does exist, however, an extensive body of literature describing both open-label and controlled studies of medications in the treatment of both children and adults with autism. Some of the better-studied medications (including haloperidol and risperidone) are often efficacious in treating associated symptoms of autism but can also cause unacceptable adverse effects. Early studies of serotonin re-uptake inhibitors appear promising but may not be indicated for all age groups. Small, controlled studies of methylphenidate and clonidine indicate a possible role for these medications in the treatment of hyperactivity in autism. No medications have been proven to be efficacious in the treatment of the core social or communication impairment seen in autism. Current pharmacological management is best aimed at target symptoms that have been demonstrated to respond to medication in treatment studies.

References

Jan 1, 1978·Journal of the American Academy of Child Psychiatry·M CampbellE J Sachar
Jul 11, 1992·Journal of the American Academy of Child and Adolescent Psychiatry·E H CookB L Leventhal
Jan 1, 1990·Journal of the American Academy of Child and Adolescent Psychiatry·F R Volkmar, D S Nelson
Jun 1, 1989·Journal of Autism and Developmental Disorders·L T AndersonJ Shell
Jan 1, 1989·Journal of the American Academy of Child and Adolescent Psychiatry·R PerryJ E Overall
Mar 1, 1988·Journal of the American Academy of Child and Adolescent Psychiatry·B BirmaherL L Greenhill
Oct 1, 1984·The American Journal of Psychiatry·L T AndersonW H Green
Jan 1, 1980·Journal of the American Academy of Child Psychiatry·I L CohenL T Anderson
Jun 1, 1995·Journal of Autism and Developmental Disorders·H QuintanaL Greenhill
Feb 1, 1995·Journal of the American Academy of Child and Adolescent Psychiatry·B K KolmenJ E Janosky
Nov 1, 1993·Journal of the American Academy of Child and Adolescent Psychiatry·M CampbellM Ernst
Oct 16, 1995·Psychiatry Research·S H Willemsen-SwinkelsH van Engeland
Nov 1, 1996·Archives of General Psychiatry·C J McDougleL H Price
Apr 1, 1996·Journal of the American Academy of Child and Adolescent Psychiatry·L E SanchezP B Adams
Nov 1, 1996·Journal of the American Academy of Child and Adolescent Psychiatry·A HardanB Hrecznyj
May 1, 1997·Journal of the American Academy of Child and Adolescent Psychiatry·C J McDougleD J Cohen
Jun 1, 1997·Journal of the American Academy of Child and Adolescent Psychiatry·M CampbellJ E Overall
Oct 1, 1996·Journal of Child and Adolescent Psychopharmacology·S Fisman, M Steele
Jul 1, 1997·Journal of Child and Adolescent Psychopharmacology·E S BrodkinL H Price
Jan 1, 1997·Journal of Child and Adolescent Psychopharmacology·R PerryR R Silva
Feb 24, 1998·Journal of Clinical Psychopharmacology·C J McDougleL H Price
Apr 17, 1998·American Journal of Mental Retardation : AJMR·P A DavanzoB H King
Apr 29, 1998·Journal of the American Academy of Child and Adolescent Psychiatry·R NicolsonL Sloman
Sep 24, 1998·Developmental Medicine and Child Neurology·G R DeLongM McSwain Kamran
Jan 9, 1999·Medical Hypotheses·E R Bolte
Jun 26, 1999·Journal of Autism and Developmental Disorders·G DelGiudice-AschE Hollander
Aug 26, 1999·Journal of Child and Adolescent Psychopharmacology·A MartinJ Bregman
Mar 14, 2000·Journal of the American Academy of Child and Adolescent Psychiatry·F R SalleeP B Chappell
Aug 2, 2000·Journal of Child Neurology·R H SandlerH M Wexler
Aug 10, 2000·Journal of Child and Adolescent Psychopharmacology·A ZuddasC Cianchetti
Oct 31, 2000·Journal of Autism and Developmental Disorders·B L HandenM Lubetsky
Dec 1, 2000·Journal of Autism and Developmental Disorders·C J McDougleD J Posey
Feb 24, 2001·Journal of the American Academy of Child and Adolescent Psychiatry·M A RiddleJ T Walkup
Mar 16, 2001·Expert Opinion on Pharmacotherapy·R L FindlingB L Gracious
Mar 1, 1961·The Journal of Pediatrics·R J SCHAIN, D X FREEDMAN

❮ Previous
Next ❯

Citations

Nov 13, 2002·Journal of Child and Adolescent Psychopharmacology·Antonio Y Hardan, Benjamin L Handen
Nov 13, 2002·Journal of Child and Adolescent Psychopharmacology·Jennifer L Couturier, Rob Nicolson
Aug 21, 2004·Journal of Child and Adolescent Psychopharmacology·Robert L FindlingJeffrey L Blumer
Oct 31, 2006·Journal of Child and Adolescent Psychopharmacology·Rob NicolsonJudy Smith
Aug 13, 2009·European Journal of Pediatrics·Jan Philipp SchuchardtAndreas Hahn
Mar 1, 2016·Experimental Neurobiology·Hye Ran ParkSun Ha Paek
Sep 14, 2004·Mental Retardation and Developmental Disabilities Research Reviews·Roberto Tuchman
Dec 14, 2004·Research in Developmental Disabilities·Robin L GabrielsEdward Goldson
Jul 22, 2005·Journal of the American Academy of Child and Adolescent Psychiatry·Jennifer L CouturierRob Nicolson
May 5, 2001·Expert Opinion on Pharmacotherapy·R L Findling
Oct 12, 2016·World Neurosurgery·Senthilkumar SivanesanJayakumar Rajadas
Apr 17, 2009·Autism : the International Journal of Research and Practice·Hans BogteHerman Van Engeland
May 22, 2004·International Journal of Psychiatry in Medicine·Marc Hertzman
May 28, 2004·Journal of Child Neurology·Miya R Asato, Antonio Y Hardan
Jul 28, 2007·Autism : the International Journal of Research and Practice·Marita BroadstockMatt Eggleston
Sep 9, 2011·The Cochrane Database of Systematic Reviews·Daniel Kl CheukWen Xiong Chen
Nov 11, 2011·The Cochrane Database of Systematic Reviews·Stephen JamesKatrina Williams
Mar 16, 2012·The Cochrane Database of Systematic Reviews·Romy HurwitzSusan Woolfenden
Jan 27, 2007·The Cochrane Database of Systematic Reviews·O S JesnerE Coren
Apr 17, 2008·Harvard Review of Psychiatry·Thomas J LeskovecRobert L Findling
Jan 1, 2010·Indian Journal of Psychological Medicine·Avinash Desousa
Apr 21, 2004·CNS Spectrums·Thomas Owley
Sep 23, 2020·Journal of Medical Case Reports·Juliana Andrea PontonRobert Lawrence Tanguay

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autism

Autism spectrum disorder is associated with challenges with social skills, repetitive behaviors, and often accompanied by sensory sensitivities and medical issues. Here is the latest research on autism.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Related Papers

Journal of the American Academy of Child and Adolescent Psychiatry
R NicolsonL Sloman
Primary Care Companion to the Journal of Clinical Psychiatry
Jean-Louis GoëbPierre Thomas
Progress in Neuro-psychopharmacology & Biological Psychiatry
Theodore Page, Charles Moseley
© 2021 Meta ULC. All rights reserved